Insights Into Helmerich & Payne (HP) Q4: Wall Street Projections for Key Metrics
Helmerich & Payne (HP) Earnings Expected to Grow: Should You Buy?
Helmerich And Payne (HP) Stock May Trade Below Fair Value On Sales
Implied Volatility Surging for Helmerich & Payne Stock Options
Helmerich & Payne, Inc. Schedules Fiscal Fourth Quarter 2026 and Year End Conference Call and Webcast
Are Investors Undervaluing Helmerich & Payne (HP) Right Now?
2 Reasons to Watch HP and 1 to Stay Cautious
UBS Maintains Buy on Helmerich & Payne, Raises Price Target to $50
Barclays Maintains Overweight on Helmerich & Payne, Raises Price Target to $51
Helmerich & Payne Q3 2026 Earnings Call Transcript
Is Helmerich & Payne (HP) Undervalued Following High End Margin Guidance And ExxonMobil Expansion?
Helmerich & Payne Expects Fiscal Q4 Direct Margins Near High End of Guidance
H&P Provides Fourth Quarter Financial & Operational Update
H&P & ExxonMobil Expand Deployment of FlexRobotics® Technology
Helmerich & Payne Expands Deployment Of FlexRobotics Technology With ExxonMobil
Susquehanna Maintains Positive on Helmerich & Payne, Raises Price Target to $50
RBC Capital Maintains Sector Perform on Helmerich & Payne, Raises Price Target to $49
Where Does Helmerich & Payne (HP) Valuation Sit On Strong Results And Outlook?
Why Is Helmerich & Payne (HP) Up 21.5% Since Last Earnings Report?
Citigroup Maintains Neutral on Helmerich & Payne, Raises Price Target to $48
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.